Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overview.

Rahvar M, Lamel SA, Maibach HI.

Immunotherapy. 2012 Sep;4(9):939-45. doi: 10.2217/imt.12.93. Review. Erratum in: Immunotherapy. 2012 Dec;4(12):1898. Rhavar, Maral [corrected to Rahvar, Maral].

PMID:
23046237
2.
3.

Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.

Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, Katsamas J.

J Am Acad Dermatol. 2009 Jun;60(6):934-43. doi: 10.1016/j.jaad.2009.01.008.

PMID:
19467365
4.

Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.

Stockfleth E, Kerl H, Zwingers T, Willers C.

Br J Dermatol. 2011 Nov;165(5):1101-8. doi: 10.1111/j.1365-2133.2011.10387.x.

PMID:
21517801
5.

Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials.

Askew DA, Mickan SM, Soyer HP, Wilkinson D.

Int J Dermatol. 2009 May;48(5):453-63. doi: 10.1111/j.1365-4632.2009.04045.x. Review. No abstract available.

PMID:
19416373
6.

Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.

Pomerantz H, Hogan D, Eilers D, Swetter SM, Chen SC, Jacob SE, Warshaw EM, Stricklin G, Dellavalle RP, Sidhu-Malik N, Konnikov N, Werth VP, Keri J, Lew R, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group.

JAMA Dermatol. 2015 Sep;151(9):952-60. doi: 10.1001/jamadermatol.2015.0502.

PMID:
25950503
7.

Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses.

Stockfleth E, Zwingers T, Willers C.

Eur J Dermatol. 2012 May-Jun;22(3):370-4. doi: 10.1684/ejd.2012.1707.

PMID:
22494856
8.
9.

Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.

Kaur RR, Alikhan A, Maibach HI.

J Dermatolog Treat. 2010 Sep;21(5):267-71. doi: 10.3109/09546630903341937. Review.

PMID:
19878034
10.

Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid--pilot study.

Schlaak M, Simon JC.

J Dtsch Dermatol Ges. 2010 Mar;8(3):174-8. doi: 10.1111/j.1610-0387.2009.07293.x. Epub 2009 Nov 2. English, German.

PMID:
19889001
11.

Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.

Couch SM, Custer PL.

Ophthal Plast Reconstr Surg. 2012 May-Jun;28(3):181-3. doi: 10.1097/IOP.0b013e3182467c68.

PMID:
22460673
12.

Treatment of actinic keratoses with topical fluorouracil.

West DA, Aires DJ.

Am Fam Physician. 2010 May 15;81(10):1186. No abstract available.

13.

Topical fluorouracil for actinic keratoses and photoaging: a clinical and molecular analysis.

Sachs DL, Kang S, Hammerberg C, Helfrich Y, Karimipour D, Orringer J, Johnson T, Hamilton TA, Fisher G, Voorhees JJ.

Arch Dermatol. 2009 Jun;145(6):659-66. doi: 10.1001/archdermatol.2009.97.

PMID:
19528421
14.

Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.

Ulrich C, Johannsen A, Röwert-Huber J, Ulrich M, Sterry W, Stockfleth E.

Eur J Dermatol. 2010 Jul-Aug;20(4):482-8. doi: 10.1684/ejd.2010.1010. Epub 2010 May 27.

PMID:
20507841
15.

Ingenol mebutate gel for actinic keratosis.

Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B.

N Engl J Med. 2012 Mar 15;366(11):1010-9. doi: 10.1056/NEJMoa1111170.

17.
18.
20.

Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.

Jarvis B, Figgitt DP.

Am J Clin Dermatol. 2003;4(3):203-13. Review.

PMID:
12627996
Items per page

Supplemental Content

Write to the Help Desk